This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bernatsky, S Articles by Hanly, J G Search for Related Content PubMed PubMed Citation Articles by Bernatsky, S Articles by Hanly, J G Social Bookmarking                         What's this?

Mortality related to cerebrovascular disease in systemic lupus erythematosus

Division of Clinical Epidemiology Montreal General Hospital, Montreal, Canada

A Clarke

Division of Clinical Epidemiology Montreal General Hospital, Montreal, Canada, Division of Clinical Immunology/Allergy, Montreal General Hospital, Montreal, Canada

D D Gladman

Toronto Western Hospital, Toronto, ON, Canada

M Urowitz

Toronto Western Hospital, Toronto, ON, Canada

P R Fortin

Toronto Western Hospital, Toronto, ON, Canada

S G Barr

University of Calgary, Calgary, AB, Canada

J-L Senécal

Division of Rheumatology, University of Montreal School of Medicine, Hôpital Notre-Dame Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Canada

M Zummer

Hôpital Maisonneuve-Rosemont, CHUM, Montreal, PQ, Canada

S Edworthy

University of Calgary, Calgary, AB, Canada

J Sibley

Department of Rheumatology, Royal University Hospital, Saskatoon, SK, Canada

J Pope

St Joseph’s Hospital, University of Western Ontario, London, ON, Canada

S Ensworth

Division of Rheumatology, Mary Pack Arthritis Centre, University of British Columbia, Vancouver, BC, Canada

R Ramsey-Goldman

Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago IL, USA

J G Hanly

Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada

The objective of this study was to examine mortality rates related to cerebrovascular disease in systemic lupus erythematosus (SLE) compared to the general population. Our sample was a multisite Canadian SLE cohort (10 centres, n = 2688 patients). Deaths due to cerebrovascular disease were ascertained by vital statistics registry linkage using ICD diagnostic codes. Standardized mortality ratio (SMR, ratio of deaths observed to expected) estimates were calculated. The total SMR for death due to cerebrovascular disease was 2.0 (95% confidence interval [CI] 1.0, 3.7). When considering specific types of events, the category with the greatest increased risk was that of ill-defined cerebrovascular events (SMR 44.9, 95% CI 9.3, 131.3) and other cerebrovascular disease (SMR 8.4, 95% CI 2.3, 21.6). Deaths due to cerebral infarctions appeared to be less common than hemorrhages and other types of cerebrovascular events. Our data suggest an increase in mortality related to cerebrovascular disease in SLE patients compared to the general population. The large increase in illdefined cerebrovascular events may represent cases of cerebral vasculitis or other rare forms of nervous system disease; alternately, it may reflect diagnostic uncertainty regarding the etiology of some clinical presentations in SLE patients. The suggestion that more deaths are attributed to cerebral hemorrhage, as opposed to infarction, indicates that inherent or iatrogenic factors (eg, thrombocytopenia or anticoagulation) may be important. In view of the paucity of large-scale studies of mortality attributed to neuropsychiatric outcomes in SLE, our findings highlight the need for additional research in large SLE cohorts.

Key Words: cerebrovascular disease • mortality • systemic lupus erythematosus

Lupus, Vol. 15, No. 12, 835-839 (2006)
DOI: 10.1177/0961203306073133


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. G. HANLY, L. SU, V. FAREWELL, G. McCURDY, L. FOUGERE, and K. THOMPSON Prospective Study of Neuropsychiatric Events in Systemic Lupus Erythematosus J Rheumatol, July 1, 2009; 36(7): 1449 - 1459. [Abstract] [Full Text] [PDF]

				T. Kleinig, B Koszyca, P. Blumbergs, and P Thompson Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus Lupus, May 1, 2009; 18(6): 486 - 490. [Abstract] [PDF]

				C. A. Heyneman Systemic Lupus Erythematosus: A Therapeutic Update Journal of Pharmacy Practice, February 1, 2009; 22(1): 29 - 52. [Abstract] [PDF]

				J. Hanly The neuropsychiatric SLE SLICC inception cohort study Lupus, December 1, 2008; 17(12): 1059 - 1063. [PDF]